Well-planned and coordinated multi-center phase I and II studies are critical for advancing the field of hematopoietic cell transplantation. To facilitate such studies, CIBMTR formed the Resource for Clinical Investigation in Blood and Marrow Transplant (RCI BMT) to provide statistical expertise and data management services for multi-center phase I and II trials.
RCI BMT studies bridge the gap between single-center studies and larger phase II and III studies conducted by the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).
To learn about current RCI BMT activities, contact Becky Drexler at rdrexler@nmdp.org.